The DOI matches its Crossref record; 982 of the 982 references it cites were found in a registry or an index.
Drug-induced liver injury
Open accessAbstract
Drug-induced liver injury (DILI) is an adverse reaction to drugs or other xenobiotics that occurs either as a predictable event when an individual is exposed to toxic doses of some compounds or as an unpredictable event with many drugs in common use. Drugs can be harmful to the liver in susceptible individuals owing to genetic and environmental risk factors. These risk factors modify hepatic metabolism and excretion of the DILI-causative agent leading to cellular stress, cell death, activation of an adaptive immune response and a failure to adapt, with progression to overt liver injury. Idiosyncratic DILI is a relative rare hepatic disorder but can be severe and, in some cases, fatal, presenting with a variety of phenotypes, which mimic other hepatic diseases. The diagnosis of DILI relies on the exclusion of other aetiologies of liver disease as specific biomarkers are still lacking. Clinical scales such as CIOMS/RUCAM can support the diagnostic process but need refinement. A number of clinical variables, validated in prospective cohorts, can be used to predict a more severe DILI outcome. Although no pharmacological therapy has been adequately tested in randomized clinical trials, corticosteroids can be useful, particularly in the emergent form of DILI related to immune-checkpoint inhibitors in patients with cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The vast majority of cases of DILI occur at therapeutic doses in a small proportion of individuals exposed to the drug, representing an idiosyncratic reaction, and therefore unpredictable based on the drug's mechanism of action and related to the uniqueness of the individual [1,2].”
From DILI Differences and Similarities between the US and Europe (2026) · cites this paper as [1]
In the citing paper
“Drug-induced liver injury (DILI) is an uncommon adverse reaction to drugs, and other chemicals, including herbal and dietary supplements (HDS).”
From DILI Differences and Similarities between the US and Europe (2026) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
Cited work 10.1128/aac.04976-14 · retracted 2015-12-28 · notice 10.1128/aac.04976-14 · this paper published 2019-08-22
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“Francis, B. et al. Temporary removal: reference intervals for putative biomarkers of drug-induced liver injury and liver regeneration in healthy human volunteers. J. Hepatol. https://doi.org/10.1016/j.jhep.2018.04.024 (2018).”
Cited work 10.1016/j.jhep.2018.04.024 · retracted 2018-05-03 · notice 10.1016/j.jhep.2018.04.024 · this paper published 2019-08-22
Citations
Cites
2 retracted
Francis, B., Clarke, J. I., Walker, L. E., Brillant, N., Jorgensen, A., Park, B. K., Pirmohamed, M., & Antoine, D. J. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.04.024 · Cited by 4
RetractedAhrens, J. H., & Sastic, C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04976-14 · Cited by 3
Retracted(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,673
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M. L., Reindollar, R., Goodman, Z. D., Koury, K. J., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,027
Research works printed but not linked: 3
- Institute of Medicine. Exploring the Biological Contributions to Human Health: Does Sex Matter? (National Academies Press, 2001).
- Sanjuan-Jimenez, R. et al. Prevalence of hepatitis E markers in Spanish patients with suspected drug-induced liver injury [abstract]. Hepatology 66, 423A (2017).
- Abu-Sbeih, H., Styskel, B., Blechazz, B., Chalasani, N. & Miller, E. Clinically significant hepatotoxicity due to immune checkpoint inhibitors is rare but leads to treatment discontinuations in high proportion. Hepatology 68, 25A (2018).
Cited by
Sorted by citations
Items 801–900 of 922
la Rosa-García, J. D. (2024) · El Repositorio Academico Digital de la UANL (Universidad Autónoma de Nuevo León)
Pelechá Salvador, M. (2023) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia)
Internship and Monograph reports entitled "Drug Induced Liver Injury"
Teixeira, M. P. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Baker, N., & Stewart, P. (2025) · Pharmaceutical Sciences and Drug Design · doi:10.51847/q6vr9ahub4
Tocotrienol as a Potential Treatment for Drug-Induced Liver Injury
Norman, N. S. S. M., Ruslan, M. R. A. R. B., Hamid, J. A., Sidik, F. Z. J., Azlina, M. F. N., & Abdullah, A. (2025) · International Journal of Pharmacology · doi:10.31083/ijp44046
Liver enzyme effects of medicinal cannabis in advanced cancer: a substudy of two randomised trials
Scarborough, L., Hardy, J. R., Gurgenci, T., Huggett, G., Pelecanos, A. M., Webb, L., Greer, R. M., & Good, P. D. (2025) · BMJ Supportive & Palliative Care · doi:10.1136/spcare-2025-005837
Tran, L. V. H., Vo, H. C., Nguyen, T. D. L., Long, T. H., Le, M.-T., Thai, K.-M., Nguyen, T. L., Tran, H. N. K., & Tran, H. N. K. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121179
Hu, Y., Hu, W., Li, D., Lan, F., He, W., Chen, M., Yao, D., Xu, J., Lai, Y., & Dai, H. (2026) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-026-05414-7
Hu, H., Jamil, S., Azmat, M. B., Alissa, M., Aloraini, G. S., Albati, A. A., Al-Emam, A., & Hassan, H. M. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103362
Huang, Y.-Q., Li, S., Wu, G., Guo, J.-J., Yang, D., Bo, Y., Yang, X., Lv, Y.-N., Zhang, Q.-R., Zhao, D., et al. (2026) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2026.100774
Envolvimento da via PPARγ nas lesões hepáticas: uma revisão de literatura
Carvalho, A. D. S., da Silva, J. D. A., do Amaral, M. C., Alves, E. H. P., Rodrigues, A. A., Sousa, S. G., BEZERRA, I. L. C., Nunes, J. M. L., MESQUITA, E. B. C., VIEIRA, A. N. G., et al. (2026) · Editora Pasteur eBooks · doi:10.59290/0102056109
Gastroenterologia e Hepatologia - Ed. XIV
de Almeida, C. C., & Freitas, G. B. L. D. (2026) · Editora Pasteur eBooks · doi:10.59290/978-65-6029-323-6
Takahashi, K. (2026) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2026.102785
Naproxen as a cause of acute cholestatic hepatitis: a case report
Maimouni, C. E., Jiménez, N., Duarte, A. O., Díaz, A., Salgado, M. C., Forns, X., & Reverter, E. (2026) · Journal of Medical Case Reports · doi:10.1186/s13256-026-05857-8
Wang, X., Wang, Y., Hu, T., & Wang, K. (2026) · Theoretical and Natural Science · doi:10.54254/2753-8818/2026.31816
Artificial Intelligence for predicting drug-likeness and bioavailability
Rajak, B. K., & Rani, P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44415-9.00011-9
Wu, L., Vllasaliu, D., Mabayoje, D. A., Aspinall, A., & Raimi‐Abraham, B. T. (2026) · Parasites & Vectors · doi:10.1186/s13071-026-07324-1
Vargas, M. F., Astbury, S., Grove, J. I., Visentin, M., Samodelov, S. L., Kullak-Ublick, G. A., & Aithal, G. P. (2026) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2026.2650183
Self-citationSpatiotemporal trends in the global burden of drug-induced chronic liver diseases in thirty years
Qian, K., Yu, L., Zhu, J., Liu, J., & Yu, Z. (2026) · Precision medication. · doi:10.1016/j.prmedi.2026.100075
Lee, D. H., Park, Y., Choi, S.-A., Song, Y., Kim, J. S., Yee, J., Han, J. M., Chang, Y., Song, T., & Gwak, H. S. (2026) · Yonsei Medical Journal · doi:10.3349/ymj.2025.0181
Effect levetiracetam drug on the liver and kidney of pregnant albino rats
Nawaf, O. A., & Yasir, S. M. (2026) · AIP conference proceedings · doi:10.1063/5.0319697
Do drugs with biliary toxicity cause cholangiocarcinoma?Preprint
Zong, C., Lim, K., Walker, S. A., Dai, R., Jeong, M. H., George, R., Jo, J. H., Iqbal, S. I., Im, H., & Weissleder, R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.31.715688
Straub, B. K., Dries, V., Breuhahn, K., Kasper, H., Drebber, U., Berger, I., Mittler, J., Roth, W., Weinmann, A., Dienes, H. P., et al. (2026) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-026-04497-z
Space of Disse on Chip Model for Study of Hepatic Toxicity and Inflammation
Mesic, A. (2025) · theses.fr (ABES) · doi:10.70675/4c19917ez1d50z4ac8za1a5zd5c8d942f244
ResDILI: Drug-Induced Liver Injury Prediction Model Using ResNet-18 and ResNet-34
Tran, T. T. V. (2026) · Communications in computer and information science · doi:10.1007/978-3-032-22059-2_35
Gupta, N., More, R., Singh, J., Parida, B. P., Anand, A., & Tiwari, A. (2026) · Research Square · doi:10.21203/rs.3.rs-8794547/v1
Ordóñez, L. F. G., Chamat, L. M. R., Cárdenas, B. R. C., & Cardoso, A. F. T. (2026) · Revista Contemporânea · doi:10.56083/rcv6n4-031
Cordycepin alleviates oxaliplatin-induced fatty liver disease
Lin, Y., Meifang, P. A. N., Tan, D., Li, T., Lu, Y., Lai, H., Wang, Z., & Liao, X. (2026) · Hepatoma Research · doi:10.20517/2394-5079.2025.81
Liu, Y., Meng, X., Zhang, W., Sun, M., Yusupov, Z., Tojibaev, K., Bobokalonov, K. A., Zhang, Z., He, M., & Jin, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1794777
Oda, S., Doki, K., Obara, N., Suzuki, Y., Sakata‐Yanagimoto, M., & Homma, M. (2026) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70585
Hepatokine ORM2 suppresses pathological ferritinophagy to prevent acute tissue injury
Tang, H., Wang, S., Liu, F., Shen, B., Jiang, F., Xiong, X., Yang, N., Zhu, H., Zhang, R., Xia, D., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08803-0
Boison, D., Barnor, J. A., Asamoah, S. A., Etwire, E. S., Akrofi, R., Antwi-Adjei, M., Armah, F. A., Kwofie, S. K., Adinortey, M. B., & Sakyi, P. O. (2026) · Research Square · doi:10.21203/rs.3.rs-9271389/v1
Cao, T., Li, M., Ma, H., & Fan, Z. (2026) · Journal of Photochemistry and Photobiology A Chemistry · doi:10.1016/j.jphotochem.2026.117323
An ICT + ESIPT synergistic NIR ratiometric probe for mitochondrial MAOs imaging in vivo and in vitro
Cao, T., Li, M., Ma, H., & Fan, Z. (2026) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-026-06537-8
СТЕПАНОВА, Т., Rozhkova, D., Byelinska, I. V., Dziubenko, N., & КУЗНЄЦОВА, Г. (2022) · Bulletin of Taras Shevchenko National University of Kyiv Series “Psychology” · doi:10.17721/1728.2748.2022.88.5-14
Yang, Y., Zhang, Y., Yang, Y., Xia, B., Zhang, H., Zhang, G., Gong, P., Qi, Y., Wu, Z., Li, C., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27094154
Recent advances in microRNA-based nanosystems for disease management: From design to applications
Gong, Y., & Dong, H. (2026) · Chinese Chemical Letters · doi:10.1016/j.cclet.2026.112900
Ye, Z., Wang, C., Chen, Y., Zeng, Y., Guo, L., Zhang, X., & Zhou, Z. (2026) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2026.110857
Pernas, S., Forns, X., Martínez-Sáez, O., Andrade, R. J., Amador, A., López-Miranda, E., Bermejo, B., Mateos, B., Solís, M. C., Villanueva, M. J., et al. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04369-7
Self-citationA subcellular spatial profiling platform for expanding the drug toxicity window
Yang, L., Bai, Q., Guo, S., Hu, L., Bi, C., Shao, L., Lin, Z., Cui, K., Yang, S., Wei, J., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.177271
Hepatotoxicitatea indusă de antimicrobiene: revizuire farmacologică
Catcov, C., Pogonea, I., Chiriac, T., Stratu, E., & Bacinschi, N. (2025) · Public Health Economy and Management in Medicine · doi:10.52556/2587-3873.2025.2(104).06
Chen, X., Liang, Z., Lu, L., Shao, Z., Tang, W., Liu, Y., Li, J., Chen, B., Lai, E., Zheng, G., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.05.006
Won, Y. J., Park, C. Y., Kim, J. H., Chang, H., Heo, S., Cha, W. C., Kim, M., Shin, Y., Xiao, K., & Kim, T. (2026) · doi:10.2196/preprints.100713
Usman-Onoruvie, V., Dele-Ochie, P. E., Adejumo, B. I. G., Oyakhire, F. O., Akhaumere, E. O., Odionyenma, U. C., Uchechukwu, D., Madompoyil, B., Odeh, B. E., Aneke, G. C., et al. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05497-1
Venkat, K. M., Zhang, Z., Zheng, K., Kota, V. G., Leo, H. L., Sun, L., & Yu, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30151-3.00007-3
., M., Negi, P., Singh, D., ., A., Kumari, S., & Ali, S. (2026) · Journal of Natural Remedies · doi:10.18311/jnr/2026/54532
Mishra, S., Suyal, P., Gola, K. K., Tiwari, S., Kanauzia, R., & Bahuguna, R. (2026) · International Conference on Intelligent Systems in Engineering, Secured Systems and Cybersecurity (ICISESSC) · doi:10.1109/icisessc68634.2026.11542591
Zhu, T., 徐爱京, Yin, W. B., & Li, C. (2026) · Journal of Immunology Research · doi:10.1155/jimr/6574389
GLOBAL RESEARCH TRENDS IN PARACETAMOL POISONING: A COMPREHENSIVE BIBLIOMETRIC ANALYSIS
Okudan, R. N., Bedel, C., Zortuk, Ö., & Selvi, F. (2026) · Ġylym men densaulyķ saķtau. · doi:10.34689/sh.2026.28.2.025
Qiu, L., Xue, M. L., Feng, H., Meng, F., Zheng, Y., Cheng, G., Zhang, Y., Yin, Z., Wu, J., Zhu, J. F., et al. (2026) · European Radiology · doi:10.1007/s00330-026-12644-y
Wang, Y., Zhang, S., Shen, M., & Zhang, K. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13780-y
Liver Disease and Plant‐Derived Phytoconstituents: From Ethnopharmacology to Modern Medicine
Pandey, B., Kharel, S., Shrestha, A., Sapkota, B., Subedi, L., & Panta, S. (2026) · Phytotherapy Research · doi:10.1002/ptr.70383
Salman, I. N., Jabbar, R. K., Emad, I., Hassan, Z. A. A., Harbi, A. M., Khudhair, A. Y., Hussein, M. A. M., Hamid, A. M., Amir, M. A. A., Ali, M. W., et al. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70268
Shin, Y., Moon, H., Lee, Y. M., & Son, M. J. (2026) · Archives of Pharmacal Research · doi:10.1007/s12272-026-01627-8
Morsi, E. A., Elsayed, M. M., Abdel-Hameed, E.-S. S., Osman, E. E. A., Aboushousha, T., & Abdel-Hady, H. (2026) · South African Journal of Botany · doi:10.1016/j.sajb.2026.06.006
Mayo, A. K., Beaudoin, J. J., Woodhead, J. L., Watkins, P. B., & Brouwer, K. L. R. (2026) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70355
Self-citationLei, Q., Zhou, J., Yuan, B., Zhao, X., Zheng, X., Ren, T., & Yuan, L. (2026) · Journal of Analysis and Testing · doi:10.1007/s41664-026-00468-0
Gao, H., Zhang, Q., Zhu, Y. U. N. L. O. N., Li, Y., Fan, K., Gao, Y., & Liu, C. (2026) · Food & Function · doi:10.1039/d6fo01629d
DILI-context: a dose- and exposure-enriched knowledge base for translational liver safety assessment
Zandie, R., Betancort, R., & Khodaee, F. (2026) · Toxicological Sciences · doi:10.1093/toxsci/kfag077
Pakal, Y. K., Dharap, N. P., Gade, S. N., & Ingole, J. R. (2026) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20262201
Wang, X., Song, W., Zhang, X., Li, Y., Sun, R., & Sun, Z. X. (2026) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2026.103603
Liver fibrosis: Pathogenesis and innovative nanoparticle-based therapeutic strategies
Cai, Y., Li, J., Chen, S., Zhang, H., Tan, J., Li, H., Zhang, S., Li, B., Wei, Q., Lin, C., et al. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100596
Zheng, Z.-Y., Chen, J.-Y., Quah, R. Y. C., Ding, G.-H., & Chen, J. (2026) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-171015
Javorac, J., Milenković, A., Vujičić, E., Kovačević, D., Rudic-Vranic, T., Mikić, D., & Živanović, D. (2026) · Vojnosanitetski pregled · doi:10.2298/vsp260329039j
Sebastian, S. A., Jose, J., & Selvam, S. (2026) · Cureus · doi:10.7759/cureus.112448
Rani, F., Biswas, S., & Verma, S. K. (2026) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2026.27.1.0384
Biomarker and Xenobiotics—Prospects for the Assessment of Exposure and Effects in Humans
Pérez-Piñar, T. (2026) · Springer eBooks · doi:10.1007/978-3-032-28619-2_6
Deng, Y., Xu, L., Niu, X., Li, J., Xiong, Y., Zhu, G., Lu, Z., Xu, C., Wang, X., Wang, P., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104296
Fang, J., Li, X., Chen, S., & Beland, F. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-59728-9
Sarma, I. D., Nath, C., Ahmed, K. A., Rajkhowa, P., Biswas, K. P., & Saikia, D. (2026) · Cureus · doi:10.7759/cureus.112820
Luo, M., Wang, Q. X., Wang, Y., Li, F., Zhang, A., & Zhao, Y. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c01434
Toxicological Evaluation of Dracaena trifasciata Methanolic Extract on Liver Function in Wistar RatsPreprint
Davies, S. I., Nwachukwu, D. C., & Kagbo, H. D. (2026) · Research Square · doi:10.21203/rs.3.rs-10436444/v1
Tran, N. T., Pham, T. M., Ngo, M. T. Q., Tran, A. V., Ninh, T. T. K., Nguyen, L. D., Hoang, D. V., & Phương, N. T. T. (2026) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986261467891
Tian, Y., Deng, L., Guo, W., Cheng, Z., Li, Y., Lu, D., Zhang, S., Zheng, J., & Liu, T. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122272
Shi, J., Ma, Y., Liu, Y., & Shi, B. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1904062
Qiu, D., Gao, Z., Zhang, L., Ma, T., Wei, X., Zhang, Z., Cao, W., Li, X., Wang, S., Deng, W., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1890794
Rahman, M. S., & Chen, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1907884
In Vitro Three-Dimensional Human Liver Model for Drug-Induced Liver and Bile Duct Injury Prediction
Fu, X., Hu, J., Jiang, X., Sun, Y., Xiang, W., Kuang, R., Kang, H., He, L., & Sang, J. (2026) · Toxics · doi:10.3390/toxics14080724
Exploring Avenues of Predicting Drug-Induced Liver Injury
Liyanarachchi, D. P. (2026) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6c00145
Zhang, J., Liu, H., Qiu, Q., Zhu, K., Ding, X., Zhao, R., Hu, T., & An, Z. (2026) · Metabolites · doi:10.3390/metabo16090614
Nakkaratniyom, T., Hirunrassamee, S., Boonchoo, T., & Sooksriwong, C. (2026) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70471
Hou, P., Zhang, Q., Liu, J., Ren, H., Qi, P., Hou, H., & Chen, S. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110455
Xiao, K., Fan, M., Zheng, H., Gu, B., Wang, S., Wu, Z., Zhang, S., Zhao, X., Zhang, W., Ning, Q., et al. (2026) · Smart Molecules · doi:10.1002/smo2.70101
Hou, X., Wang, Z., Li, J., Li, C., Xu, Z., Lu, Q., Huang, J., & James, T. D. (2026) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2026.140851
Zhao, P., Wu, T., Zhang, S., Li, C., Wei, P., & Zhu, Y. (2026) · Materials Today Chemistry · doi:10.1016/j.mtchem.2026.104008
Hu, J., Zhang, Y., Wang, M., Zhang, B., Zhang, B., Ke, C., Tang, C., Xia, J., Zhao, Q., Gao, H., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00175
Taha, H. M., Khalifa, B. H., Hassan, M. Y., & Taha, K. H. (2026) · Case Reports in Hepatology · doi:10.1155/crhe/2519455
Soundharya, H., Pallavi, J., Naskar, R., Medishetti, R., Sedam, S. M., Chatti, K., Parsa, K. V. L., & Chakraborty, S. (2026) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6c00322
Acetaminophen-induced acute liver injury abrogates the cytosine methylation pathway
Ara, D., Ziona, B., & Mungamuri, S. K. (2026) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-026-00659-1
Cai, Z., Zhao, H., Wei, M., Cheng, Z., He, H., Xu, J., Xu, S., Huang, J., Xiao, T., Peng, J., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103694
Luty, M., Borah, D., Szafranska, K., Giergiel, M., Trzos, K., McCourt, P., Malgorzata, L., Kotlinowski, J., & Zapotoczny, B. (2026) · Scientific Reports · doi:10.1038/s41598-026-71452-y
Wang, C., Ding, W., Yao, S., Li, Y., He, W., Guo, Z., & Chen, Y. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c04737
Hameed, A. L., Abbas, M. A., Halmi, F. T. M., Shemiss, L. E., Abdullah, S. M. Z., Alamdar, S. N. A., Salahaddin, M. D., Motib, A. S., Awla, H. K., Smail, S. W., et al. (2026) · Future Science OA · doi:10.1080/20565623.2025.2563488
Wang, T., Bacot, S. M., Patterson, K., Friedman, D., Taylor, C., Hong, H., Liu, J., Avigan, M., Hayashi, P. H., Rule, J. A., et al. (2026) · Liver International · doi:10.1111/liv.70895
Drug clustering upon toxicity effects on liver spheroids – a deep learning approach
Jordović-Pavlović, M. I., Geroski, T., & Nikolic, M. M. (2026) · IEEE Lasers and Electro-Optics Society Annual Meeting (LEOS) · doi:10.46793/et26.d11jp
Mohit Kumar, P. S. G. (2025) · International Journal of Environmental Sciences · doi:10.64252/0kz6wa68
Idakwoji, P. A., Hamza, Y., Suleiman, S. G., Nwabuogor, O. A., Ezeizu, V. C., Temitayo, I. A., Onwuchekwa, N., Ojo, S. S., Samuel, O. O., & Idris, K. Z. (2026) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2026.100608
Noori, N. (2026) · Репродуктивная медицина (Центральная Азия) · doi:10.37800/rm.3.2026.803
Metadata
- Authors
- Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., & Aithal, G. P.
- Affiliations
- Indiana University School of Medicine (US)
- Duke University (US)
- Novartis (Switzerland) (CH)
- University of North Carolina at Chapel Hill (US)
- St.John's Medical College Hospital (IN)
- University of Zurich (CH)
- Spanish Clinical Research Network (ES)
- Nottingham University Hospitals NHS Trust (GB)
- Corresponding author
- Lucena, M. Isabel
- ORCID
- Venue
- Nature Reviews Disease Primers
- Published
- 2019-08-22
- Volume
- 5
- Issue
- 1
- Pages
- 58-58
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W1565605888
- Cited by
- 924
- References
- 982
- Citations by year
- 2026: 152 · 2025: 197 · 2024: 161 · 2023: 127 · 2022: 145 · 2021: 97 · 2020: 38
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.zora.uzh.ch
- Licence
- Locations
- Nature Reviews Disease Primers (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by-nc-nd)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- drug-induced liver injury, idiosyncratic drug reactions, xenobiotic toxicity, genetic susceptibility, hepatic metabolism, immune response, corticosteroids, immune checkpoint inhibitors, hepatotoxicity
- MeSH terms
- Biopsy, Humans, Risk Factors, Biomarkers, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
